Literature DB >> 25447523

Calcium release-activated calcium (CRAC) channels mediate the β(2)-adrenergic regulation of Na,K-ATPase.

Michael J Keller1, Emilia Lecuona2, Murali Prakriya3, Yuan Cheng1, Saul Soberanes1, G R Scott Budinger1, Jacob I Sznajder1.   

Abstract

β2-Adrenergic agonists have been shown to regulate Na,K-ATPase in the alveolar epithelium by recruiting Na,K-ATPase-containing vesicles to the plasma membrane of alveolar epithelial cells (AEC). Here, we provide evidence that β2-agonists induce store-operated calcium entry (SOCE) in AECs. This calcium entry is necessary for β2-agonist-induced recruitment of Na,K-ATPase to the plasma membrane of AECs. Specifically, we show that β2-agonists induce SOCE via stromal interaction molecule 1 (STIM1)-associated calcium release-activated calcium (CRAC) channels. We also demonstrate that the magnitude of SOCE affects the abundance of Na,K-ATPase at the plasma membrane of AECs.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calcium channel; Calcium signaling; Epithelial cell; Na,K-ATPase; Store-operated calcium entry

Mesh:

Substances:

Year:  2014        PMID: 25447523      PMCID: PMC4267986          DOI: 10.1016/j.febslet.2014.10.041

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  37 in total

Review 1.  Crosstalk between cAMP and Ca2+ signaling in non-excitable cells.

Authors:  Jason I E Bruce; Stephen V Straub; David I Yule
Journal:  Cell Calcium       Date:  2003-12       Impact factor: 6.817

Review 2.  Alveolar epithelial beta 2-adrenergic receptors: their role in regulation of alveolar active sodium transport.

Authors:  Gökhan M Mutlu; Walter J Koch; Phillip Factor
Journal:  Am J Respir Crit Care Med       Date:  2004-09-24       Impact factor: 21.405

Review 3.  Mechanisms of pulmonary edema clearance.

Authors:  Gökhan M Mutlu; Jacob I Sznajder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-11       Impact factor: 5.464

4.  Isoproterenol improves ability of lung to clear edema in rats exposed to hyperoxia.

Authors:  F J Saldías; A Comellas; K M Ridge; E Lecuona; J I Sznajder
Journal:  J Appl Physiol (1985)       Date:  1999-07

Review 5.  New insights into the molecular mechanisms of store-operated Ca2+ signaling in T cells.

Authors:  Riina M Luik; Richard S Lewis
Journal:  Trends Mol Med       Date:  2007-01-30       Impact factor: 11.951

6.  The GTP-binding protein RhoA mediates Na,K-ATPase exocytosis in alveolar epithelial cells.

Authors:  Emilia Lecuona; Karen Ridge; Liuska Pesce; Daniel Batlle; Jacob I Sznajder
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

7.  A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function.

Authors:  Stefan Feske; Yousang Gwack; Murali Prakriya; Sonal Srikanth; Sven-Holger Puppel; Bogdan Tanasa; Patrick G Hogan; Richard S Lewis; Mark Daly; Anjana Rao
Journal:  Nature       Date:  2006-04-02       Impact factor: 49.962

8.  Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury.

Authors:  Daniel F McAuley; James A Frank; Xiaohui Fang; Michael A Matthay
Journal:  Crit Care Med       Date:  2004-07       Impact factor: 7.598

9.  Isoproterenol increases Na+-K+-ATPase activity by membrane insertion of alpha-subunits in lung alveolar cells.

Authors:  A M Bertorello; K M Ridge; A V Chibalin; A I Katz; J I Sznajder
Journal:  Am J Physiol       Date:  1999-01

10.  Modulation of lung liquid clearance by isoproterenol in rat lungs.

Authors:  F Saldías; E Lecuona; E Friedman; M L Barnard; K M Ridge; J I Sznajder
Journal:  Am J Physiol       Date:  1998-05
View more
  2 in total

1.  Identification of transcriptional biomarkers by RNA-sequencing for improved detection of β2-agonists abuse in goat skeletal muscle.

Authors:  Luyao Zhao; Shuming Yang; Yongyou Cheng; Can Hou; Xinyong You; Jie Zhao; Ying Zhang; Wenjing He
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

2.  Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor.

Authors:  Konstantinos Alevizopoulos; Konstantinos Dimas; Natalia Papadopoulou; Eva-Maria Schmidt; Anna Tsapara; Saad Alkahtani; Sabina Honisch; Kyriakos C Prousis; Saud Alarifi; Theodora Calogeropoulou; Florian Lang; Christos Stournaras
Journal:  Oncotarget       Date:  2016-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.